TNF-related apoptosis-inducing ligand (TRAIL) and erythropoiesis:: a role for PKCε

被引:0
|
作者
Vitale, M
Gobbi, G
Mirandola, P
Ponti, C
Sponzilli, I
Rinaldi, L
Manzoli, FA
机构
[1] Univ Parma, Osped Maggiore, Dept Anat Pharmacol & Forens Med, Human Anat Sect, I-43100 Parma, Italy
[2] Univ Trieste, Dept Normal Human Morphol, I-34127 Trieste, Italy
[3] Univ Bologna, Dept Anat Sci, I-40126 Bologna, Italy
来源
EUROPEAN JOURNAL OF HISTOCHEMISTRY | 2006年 / 50卷 / 01期
关键词
PKC epsilon; erythropoiesis; EPO; CD34; apoptosis; TRAIL;
D O I
暂无
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The regulation of the hematopoietic stem cell pool size and the processes of cell differentiation along the hematopoietic lineages involve apoptosis. Among the different factors with a recognized activity on blood progenitor cells, TRAIL a member of the TNF family of cytokines - has an emerging role in the modulation of normal hematopoiesis. PKC epsilon levels are regulated by EPO in differentiating erythroid progenitors and control the protection against the apoptogenic effect of TRAIL. EPO-incluced erythroid CD34 cells are insensitive to the apoptogenic effect of TRAIL between day 0 and day 3, due to the lack of specific surface receptors expression. Death receptors appear after day 3 of differentiation and consequently erythoid cells become sensitive to TRAIL up to day 9/10, when the EPO-driven up-regulation of PKC epsilon intracellular levels inhibits the TRAIL-mediated apoptosis, via Bcl-2. In the time interval between day 3 and 9, therefore, the number of erythroid progenitors can be limited by the presence of soluble or membrane-bound TRAIL present in the bone marrow microenvironment.
引用
收藏
页码:15 / 18
页数:4
相关论文
共 50 条
  • [21] Importance of TNF-related apoptosis-inducing ligand in pathogenesis of interstitial cystitis
    Kutlu, Omer
    Akkaya, Erdem
    Koksal, Ismail Turker
    Bassorgun, Ibrahim Cumhur
    Ciftcioglu, Mehmet Akif
    Sanlioglu, Salih
    Kukul, Erdal
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2010, 42 (02) : 393 - 399
  • [22] The promise of cancer therapeutics targeting the TNF-related apoptosis-inducing ligand and TRAIL receptor pathway
    S Wang
    Oncogene, 2008, 27 : 6207 - 6215
  • [23] The promise of cancer therapeutics targeting the TNF-related apoptosis-inducing ligand and TRAIL receptor pathway
    Wang, S.
    ONCOGENE, 2008, 27 (48) : 6207 - 6215
  • [24] TNF-related apoptosis-inducing ligand (TRAIL): A new path to anti-cancer therapies
    Holoch, Peter A.
    Griffith, Thomas S.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2009, 625 (1-3) : 63 - 72
  • [25] Stability and bioactivity of nanocomplex of TNF-related apoptosis-inducing ligand
    Na, Seong Ju
    Chae, Su Young
    Lee, Seulki
    Park, Kyeongsoon
    Kim, Kwangmeyung
    Park, Jae Hyung
    Kwon, Ick Chan
    Jeong, Seo Young
    Lee, Kang Choon
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2008, 363 (1-2) : 149 - 154
  • [26] TNF-related apoptosis-inducing ligand (TRAIL) protects against diabetes and atherosclerosis in Apoe−/− mice
    B. A. Di Bartolo
    J. Chan
    M. R. Bennett
    S. Cartland
    S. Bao
    B. E. Tuch
    M. M. Kavurma
    Diabetologia, 2011, 54 : 3157 - 3167
  • [27] Cancer: Novel therapeutic strategies that exploit the TNF-related apoptosis-inducing ligand (TRAIL)/TRAIL receptor pathway
    Cretney, Erika
    Takeda, Kazuyoshi
    Smyth, Mark J.
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2007, 39 (02) : 280 - 286
  • [28] Evidence for a proangiogenic activity of TNF-related apoptosis-inducing ligand
    Secchiero, P
    Gonelli, A
    Carnevale, E
    Corallini, F
    Rizzardi, C
    Zacchigna, S
    Melato, M
    Zauli, G
    NEOPLASIA, 2004, 6 (04): : 364 - 373
  • [29] Vemurafenib may overcome TNF-related apoptosis-inducing ligand (TRAIL) resistance in anaplastic thyroid cancer cells
    Pilli, Tania
    Cantara, Silvia
    Marzocchi, Carlotta
    Pacini, Furio
    Prabhakar, Bellur S.
    Castagna, Maria Grazia
    ENDOCRINE, 2020, 67 (01) : 117 - 123
  • [30] TNF-related apoptosis-inducing ligand (TRAIL) for bone sarcoma treatment: Pre-clinical and clinical data
    Gamie, Zakareya
    Kapriniotis, Konstantinos
    Papanikolaou, Dimitra
    Haagensen, Emma
    Ribeiro, Ricardo Da Conceicao
    Dalgarno, Kenneth
    Krippner-Heidenreich, Anja
    Gerrand, Craig
    Tsiridis, Eleftherios
    Rankin, Kenneth Samora
    CANCER LETTERS, 2017, 409 : 66 - 80